Co-prescription of aripiprazole on prolactin levels in long-term hospitalized chronic schizophrenic patients with co-morbid type 2 diabetes: A retrospective clinical study

BACKGROUND: One of the most frequent side effects of atypical antipsychotics is hyperprolactinemia (HPRL), and metformin or aripiprazole co-prescription is regarded as an effective therapy option for reducing prolactin (PRL) levels. However, whether either of the two drugs can reduce PRL levels in p...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xuebing, Sun, Xianzhi, Li, Lu, Zeng, Kuan, Li, Yi, Gao, Yujun, Ma, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933920/
https://www.ncbi.nlm.nih.gov/pubmed/36816406
http://dx.doi.org/10.3389/fpsyt.2023.1124691

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933920/
https://www.ncbi.nlm.nih.gov/pubmed/36816406
http://dx.doi.org/10.3389/fpsyt.2023.1124691

Ejemplares similares